Long-term outcome in epilepsy with grand mal on awakening: forty years of follow-up

Ann Neurol. 2014 Feb;75(2):298-302. doi: 10.1002/ana.24103. Epub 2014 Feb 20.

Abstract

Epilepsy with grand mal on awakening (EGMA) is a well-defined subtype of idiopathic generalized epilepsy. Patients with follow-up of at least 20 years were assessed retrospectively regarding 5-year terminal seizure remission. Forty-two patients were included (mean age=60 ± 13 years). After follow-up of 40 ± 13 years, 26 patients (62%) were in remission, 5 without antiepileptic drugs. Age at investigation (odds ratio=0.939, 95% confidence interval=0.887-0.994, p=0.029) independently predicted lacking remission. Nineteen patients (45.2%) had withdrawn from antiepileptic drugs at least once; 12 of those (63.2%) had seizure relapse. EGMA has a favorable long-term prognosis. With increasing age and treatment duration, antiepileptic drug withdrawal may be justified.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anticonvulsants / therapeutic use
  • Female
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Social Behavior
  • Status Epilepticus / complications*
  • Status Epilepticus / drug therapy
  • Status Epilepticus / epidemiology*
  • Status Epilepticus / mortality
  • Treatment Outcome*

Substances

  • Anticonvulsants